Your browser doesn't support javascript.
loading
Inhibition of Aurora A Kinase in Combination with Chemotherapy Induces Synthetic Lethality and Overcomes Chemoresistance in Myc-Overexpressing Lymphoma.
Park, Steven I; Lin, Carolina P; Ren, Natalie; Angus, Steven P; Dittmer, Dirk P; Foote, Michael; Parton, Trevor; Bhatt, Aadra P; Fedoriw, Yuri D; Roth, Daniel P; Cann, Marissa L; Johnson, Gary L; Damania, Blossom.
Afiliación
  • Park SI; Levine Cancer Institute, Atrium Healthcare, 1021 Morehead Medical Drive, Building 2, Suite 20121, Charlotte, NC, 28204, USA. steven.park@atriumhealth.org.
  • Lin CP; UNC School of Medicine, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA. steven.park@atriumhealth.org.
  • Ren N; UNC School of Medicine, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
  • Angus SP; UNC School of Medicine, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
  • Dittmer DP; UNC School of Medicine, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
  • Foote M; UNC School of Medicine, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
  • Parton T; UNC School of Medicine, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
  • Bhatt AP; UNC School of Medicine, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
  • Fedoriw YD; UNC School of Medicine, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
  • Roth DP; UNC School of Medicine, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
  • Cann ML; UNC School of Medicine, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
  • Johnson GL; UNC School of Medicine, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
  • Damania B; UNC School of Medicine, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
Target Oncol ; 14(5): 563-575, 2019 10.
Article en En | MEDLINE | ID: mdl-31429028
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pirimidinas / Azepinas / Linfoma no Hodgkin / Proteínas Proto-Oncogénicas c-myc / Ciclofosfamida / Aurora Quinasa A / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Target Oncol Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pirimidinas / Azepinas / Linfoma no Hodgkin / Proteínas Proto-Oncogénicas c-myc / Ciclofosfamida / Aurora Quinasa A / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Target Oncol Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos